Skip to main content
Medical information Clinical review pending

Gastroenterology Testing

Hepatitis B Surface Antibody Anti HBs Test

The Hepatitis B Surface Antibody (Anti-HBs) test checks for immunity to the Hepatitis B virus (HBV). It helps determine if you are protected, either through vaccination or past infection.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Blood sample (serum or plasma).
Results
Confirm with the laboratory before booking.
Preparation
No special preparation is required. Confirm with the laboratory before booking.
Test priceKSh 1,684

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Hepatitis B Surface Antibody Anti HBs Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Confirming immunity after Hepatitis B vaccination
  • ✓Evaluating potential exposure to Hepatitis B virus
  • ✓Screening individuals with risk factors for HBV
  • ✓Assessing immunity status in healthcare workers
  • ✓Monitoring response to Hepatitis B vaccination
02

In plain language

What this test helps you understand

This test determines immunity to the Hepatitis B virus (HBV), indicating protection from infection either through vaccination or prior infection. It helps assess the need for vaccination or further evaluation.
The Hepatitis B Surface Antibody (Anti-HBs) test is a diagnostic tool used to determine immunity against the Hepatitis B virus (HBV). This test is important for individuals who may have been exposed to the virus or are at risk of infection. Understanding your immunity status is crucial for preventing complications associated with Hepatitis B, such as liver disorders.

This test measures the presence of antibodies to the Hepatitis B surface antigen (HBsAg) in your blood. A positive result indicates that you have developed immunity to the virus, either through vaccination or recovery from a past infection.

Individuals who should consider this test include those who have been vaccinated against Hepatitis B and want to confirm their immunity, individuals who have had potential exposure to the Hepatitis B virus, and people with risk factors such as multiple sexual partners, sharing needles, or healthcare workers.

Taking this test helps assess your immunity status against Hepatitis B and can provide peace of mind if you have been vaccinated or previously infected. Discussing your results with a healthcare provider is recommended for a comprehensive understanding and guidance on next steps.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo special preparation is required. Confirm with the laboratory before booking.
SampleBlood sample (serum or plasma).
MethodologyImmunoassay (e.g., ELISA, Chemiluminescence). Confirm with the laboratory before booking.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test only indicates the presence or absence of Anti-HBs antibodies. It does not differentiate between immunity from vaccination and immunity from past infection. Other tests may be needed for a complete HBV status assessment.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

A positive result generally indicates that you have immunity to Hepatitis B, either from vaccination or a previous infection.
A negative result suggests you are not immune to Hepatitis B and may be susceptible to infection. Vaccination might be recommended.
No, fasting is generally not required for this test. However, please confirm with the laboratory before booking.
Turnaround time varies. Please confirm the expected timeframe with the laboratory before booking.
Insurance coverage varies. Please check with your insurance provider regarding coverage for this specific test.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp